心血管疾患との闘いにおける栄養の重要な役割

[1] 世界保健機関：心血管疾患ファクトシート、2016年9月 http://www.who.int/mediacentre/factsheets/fs317/en/

[2] Heidereich, P, et al. 米国における心血管疾患の将来予測、Circulation.

[3] Factsheet: Cardiovascular disease in China, World Heart Federation, 2016 http://www.world-heart federation.org/fileadmin/user_upload/documents/Fact_sheets/2016/Cardiovascular_diseases_in_China.pdf

[4] http://www.who.int/cardiovascular_diseases/publications/atlas_cvd/en/ 

[5] Micha et al, Association between dietary factors and mortality from heart disease, stroke and type 2 diabetes in the United States, J Am Med Soc, 2017, doi:10.1001/jama.2017.0947

[6] Estruch et al, PREDIMED Study Investigators. N Engl J Med, 2013 Apr 4;368(14):1279-90

[7] http://www.heart.org/HEARTORG/Conditions/More/Diabetes/WhyDiabetesMatters/Cardiovascular-Disease-Diabetes_UCM_313865_Article.jsp#.WIDO8YXXJMs

[8] Van Horn et al, Recommended dietary pattern to achieve adherence to American Heart Association/American College of Cardiology (AHA/ACC). Guidelines: A scientific statement from the AHA, Circulation 2016 https://www.ncbi.nlm.nih.gov/pubmed/27789558. 

[9] Gaksch et al, Vitamin D and mortality: Individual participant data meta-analysis of standardized 25-hydroxyvitamin D in 26,916 individuals from European consortium. PLoS One, 2017 Feb 16;12(2:e0170791)

[10] Starkら、健康な成人の血流中のオメガ3脂肪酸、ドコサヘキサエン酸とエイコサペンタエン酸の世界的調査 Prog Lipid Res.

[11] Perk et al, European Guidelines on cardiovascular disease prevention in clinical practice (version 2012), European Heart Journal 2012 http://eurheartj.oxfordjournals.org/content/33/13/1635.short

[12] D Colosia, 観察研究における2型糖尿病患者の高血圧と肥満の有病率：系統的文献レビュー, Diabetes Metab Syndr Obes 2013 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3798927/ 

[13] Williams CL et al, Dietary patterns and cardiovascular disease, ProcNutr Soc 2013 https://www.ncbi.nlm.nih.gov/pubmed/23953031

[14] Reedy J et al, Higher diet quality is associated with decrease risk of all-cause, cardiovascular disease and cancer mortality among older adults, J Nutr 2014 https://www.ncbi.nlm.nih.gov/pubmed/24572039.

[15] Stradling C et al, A review of dietary influences on cardiovascular heath: part 2: dietary patterns, Cardiovasc Hematol Disord Drug Targets 2014 https://www.ncbi.nlm.nih.gov/pubmed/24993125

[16] Mozaffarian et al, Plasma phospholipid long-chain -3 fatty acids and total and cause-specific mortality in older adults: cohort study, Ann Intern Med 2013, and Arnoldussen et al, Early intake of long-chain polyunsaturated fatty acids preserves brain structure and function in diet-induced obesity, J Nutr Biochem 2016 https://www.ncbi.nlm.nih.gov/pubmed/27012634 

[17] 欧州連合官報（25.2.12）2012年5月16日付欧州委員会規則（EU）432/2012号

[18] 2013年6月11日付欧州委員会規則（EU）536/2013

[19] Alexander, D, et al. A meta-analysis of randomized controlled trials and prospective cohort studies of eicosapentaenoic and docosahexaenoic long-chain omega-3 fatty acids and coronary heart disease risk, Mayo Clinic Proceedings2017 http://www. mayoclinicproceedings.org/article/S0025 6196%2816%2930681-4/abstract

[20] Piepoli et al, Authors/Task Force Members. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (臨床における心血管疾患予防に関する欧州心臓病学会およびその他の学会の第6合同タスクフォース) (10学会の代表者および招待された専門家によって構成) Developed with special contribution of European Association for Cardiovascular Prevention& Rehabilitation (EACPR). Eur Heart J. 2016 Aug 1;37(29:2315-81. 

[21] Rice et al, Conducting omega-3 clinical trials with cardiovascular outcomes: Proceedings of workshop held at ISSFAL 2014. Prostaglandins Leukot Essent Fatty Acids. 2016;107:30-42

[22] Siscovick et al, Omega-3 Polyunsaturated Fatty Acid (Fish Oil) Supplementation and Prevention of Clinical Cardiovascular Disease: A Science Advisory From the American Heart Association. Circulation. 2017 Mar 13.

[23] Zhang et al, Serum 25-hydroxyvitamin D and risk of cardiovascular disease: dose-response meta-analysis of prospective studies. 2017 Mar 1.

[24] Sigmundら、ビタミンD(3)によるレニン発現と血圧の調節、J Clin Invest, 2002 https://www.jci.org/articles/view/16160 

[25] Kunutsor et al, Vitamin D and risk of future hypertension: meta-analysis of 283,537 participants, Eur J Epidemiol, 2013 https://www.ncbi.nlm.nih.gov/pubmed/23456138

[26] Chowdhury et al, Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational cohort and randomised intervention studies.

[27] EFSA、ビタミンDの耐容上限摂取量に関する科学的意見。

[28] Rimmら、血管疾患のための抗酸化物質、Med Clin North Am、2000年 

[29] Raederstorff et al, Vitamin E function and requirements in relation to PUFA, Br J of Nutrition, 2015

[30] Ashor et al, 抗酸化ビタミンの補給は成人における動脈硬化を軽減する：ランダム化比較試験のシステマティックレビューとメタアナリシス, J Nutr, 2014 http://jn.nutrition.org/content/early/2014/08/06/jn.114.195826

[31] Blockら、血漿中のビタミンCは、若い黒人および白人女性の血圧および前年度の血圧変化と逆相関している、Nutr J, 2008 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2621233/

[32] Carr et al, Toward new recommended dietary allowance for vitamin C based on antioxidative and health effects in humans, Am J of Clin Nutr, 1999 https://www.ncbi.nlm.nih.gov/pubmed/10357726 

[33] Whitehead A, Beck EJ, Tosh S, Wolever TMS, Cholesterol lowering effects of oat b-glucan: a meta analysis of randomized controlled trials'; American Journal of Clinical Nutrition, doi 10.3945/ajcn.114.086108.

[34] 2011年11月14日付欧州委員会規則（EU）1160/2011